ImageneBio, Inc. (IMA) vs INmune Bio, Inc. (INMB)
ImageneBio, Inc. and INmune Bio, Inc. are both Biotechnology companies. ImageneBio, Inc. and INmune Bio, Inc. are of similar size ($55.5M and $52.9M). INmune Bio, Inc. grew revenue faster over the last twelve months: −51.6% against −68.0%. Across the 13 metrics below, ImageneBio, Inc. leads on 8 and INmune Bio, Inc. on 5.
Valuation
Profitability
| Metric | IMA | INMB | Biotechnology median |
|---|---|---|---|
| Gross margin | 100.00% | 100.00% | 65.16% |
| Operating margin | 0.00% | 0.00% | 0.00% |
| Net margin | 0.00% | 0.00% | 0.00% |
| Free cash flow margin | 0.00% | 0.00% | 0.00% |
| Return on equity | (41.34%) | (74.82%) | (57.72%) |
| Return on assets | (38.34%) | (57.08%) | (49.22%) |
| Return on invested capital | (622.37%) | (646.94%) | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack